<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, we have recently shown that ERAP2 as well as ERAP1 may be secreted from MDM under inflammatory stimuli [
 <xref rid="B19-cells-09-00720" ref-type="bibr">19</xref>,
 <xref rid="B20-cells-09-00720" ref-type="bibr">20</xref>]. Notably, the addition of recombinant human (rh)ERAP2 to PBMC drastically reduced HIV infection leading to an increased T-cell activation and a decreased percentage of terminal differentiated CD8
 <sup>+</sup> T lymphocyte (TEMRA) [
 <xref rid="B20-cells-09-00720" ref-type="bibr">20</xref>]. The mechanism by which exogenous ERAP2 interferes with HIV-1 infection/replication is under investigation. However, the observation that HIV replication is partially reduced by rhERAP2 addition even when cell cultures are CD8
 <sup>+</sup> T cells-depleted suggests that such an effect is not exclusively dependent on CD8
 <sup>+</sup> T cells [
 <xref rid="B20-cells-09-00720" ref-type="bibr">20</xref>].
</p>
